Iconplc.com Website Review

Our services span the entire lifecycle of product development and commercialisation, and can be adapted to suit small local trials or Integrated services that cover planning, management, execution and an*lysis. We have extensive experience in a broad range of thera*eutic areas. Managing studies in all major geographies, we have established solid ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR-T therapies. Offering solutions that combine in-house expertise and proprietary innovative technology. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development Using data to design, simulate, and an*lyse adaptive clinical trials with ease. Digital solutions that increase efficiency in clinical trials by driving site performance. BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges. ICON provides an*lysis and key insights on these challenges, with practical advice and recommendations. Remote monitoring and leveraging wearable devices and sensors in clinical trials. savings. Results from an industry survey by ICON and Pharma Intelligence. ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards. ICON experts frequently author or contribute to industry trade press. Read some recent articles. Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities. Explore how mapping stakeholder value can help drive profitable device development programmes in increasingly value driven markets ICON & Informa survey of industry executives Read the whitepaper